Orthopedic Department, Shandong University Affiliated Provincial Hospital, Jinan, China.
Ir J Med Sci. 2010 Dec;179(4):529-34. doi: 10.1007/s11845-010-0537-8. Epub 2010 Aug 17.
Cell-based tissue engineering has emerged as a potential therapy for intervertebral disc degeneration. However, propagating and maintaining high quantity and quality of the seed cells remains a challenge.
To investigate the feasibility of culturing human disc cells using a microcarrier bioreactor system.
Cell counts, growth patterns, cell cycles and cellular viability were examined during the course of cell cultivation and compared between the microcarrier bioreactor culture system and the conventional monolayer culture.
Cultures in the microcarrier bioreactor resulted in enhanced disc cell growth and satisfactory cell viability in comparison with the conventional monolayer culture. The cells in the microcarrier bioreactor cultivation exhibited higher S phase ratios, elevated mitotic index and persistent exponential growth.
The microcarrier bioreactor culture system appears suitable for human disc cell propagation and may provide considerably more seeding cells for the tissue engineering process of intervertebral discs.
基于细胞的组织工程已成为治疗椎间盘退变的一种有潜力的方法。然而,大量且高质量地扩增种子细胞仍然是一个挑战。
研究使用微载体生物反应器系统培养人椎间盘细胞的可行性。
在细胞培养过程中检查细胞计数、生长模式、细胞周期和细胞活力,并将其与微载体生物反应器培养系统和传统单层培养进行比较。
与传统的单层培养相比,微载体生物反应器培养可促进椎间盘细胞生长,并保持良好的细胞活力。微载体生物反应器培养的细胞具有更高的 S 期比例、更高的有丝分裂指数和持续的指数增长。
微载体生物反应器培养系统似乎适合人椎间盘细胞的扩增,可为椎间盘组织工程过程提供更多的种子细胞。